Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 3649 - 3656 of 12094 results

MLS Election Update: Clean Tech, Energy & Environment
November 9, 2020| Blog| Viewpoint

MintzEdge Entrepreneur Perspective: Building a Point of Care Medical Diagnostic Co. During COVID-19
November 9, 2020| Podcast| Viewpoint

DEA Releases Long-Awaited Suspicious Orders Proposed Rule
November 6, 2020| Blog| Viewpoint

‘Too Old’ to Be CEO — Bias Charges in Succession Plan
November 6, 2020| News

FCC Opens Application Portal for $100 Million in Funding to Support Connected Care Services
November 6, 2020| Alert| Viewpoint

California Privacy Rights Act Passes - Dramatically Altering the CCPA
November 6, 2020| Blog| Viewpoint

Why Royalty Monetization Transactions Are Big News for Life Sciences Innovators
November 6, 2020| News

An Update on FDA’s Contribution to COVID-19 Diagnostic Testing
November 5, 2020| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
